Index of artpub/2017/pmc_28899363/

Reynolds, Kerry Lynn
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer
2017
https://ddd.uab.cat/record/186327
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Reynolds,_Kerry_Lynn2022-06-29 13:32 21  
[ ]2=A_phase_I_open-label_dose-escalation_study...2022-06-29 13:32 220  
[ ]3=20172022-06-29 13:32 5  
[ ]4=1863272022-06-29 13:32 34  
[TXT]pmc_28899363.dirinfo2025-02-07 02:56 341  
[ ]pmc_28899363.du2025-02-07 02:56 33  
[TXT]pmc_28899363.dupdirs2025-02-07 02:56 0  
[TXT]pmc_28899363.dupfiles2025-02-07 02:56 0  
[TXT]pmc_28899363.errors2025-02-07 02:56 0  
[IMG]pmc_28899363.gif2025-02-07 02:56 48K 
[IMG]pmc_28899363.ico2025-02-07 02:56 12K 
[TXT]pmc_28899363.info2025-02-07 02:56 52K 
[TXT]pmc_28899363.md52025-02-07 02:56 51  
[ ]pmc_28899363.pdf2025-02-07 02:56 543K 
[TXT]pmc_28899363.sha12025-02-07 02:56 59  
[TXT]pmc_28899363.sha2562025-02-07 02:56 83  
[TXT]pmc_28899363.stats2025-02-07 02:56 293  
[TXT]pmc_28899363.txt2025-02-07 02:56 74K